Stopping the control arm in response to the DSMB: mother's choice of HIV prophylaxis during breastfeeding in the BAN Study
- PMID: 22041453
- PMCID: PMC3253884
- DOI: 10.1016/j.cct.2011.10.006
Stopping the control arm in response to the DSMB: mother's choice of HIV prophylaxis during breastfeeding in the BAN Study
Abstract
The Data and Safety Monitoring Board (DSMB) for the Breastfeeding, Antiretrovirals, and Nutrition study, a clinical trial aimed to prevent postnatal HIV transmission, recommended halting randomization to the enhanced standard-of-care (control) arm. The 67 mother-infant pairs on the control arm and less than 21 weeks postpartum at the time of the DSMB recommendation were read a script informing them of the DSMB decision and offering them the maternal or infant antiretroviral interventions for the remainder of the 28-week breastfeeding period. This paper describes the BAN study response to the DSMB decision and what the women on the control arm chose, when given a choice to start the maternal or infant antiretroviral interventions.
Published by Elsevier Inc.
Figures
References
-
- Geneva: Joint United Nations Programme on HIV/AIDS; 2009. AIDS Epidemic Update.
-
- WHO Collaborative Study Team on the Role of Breastfeeding on the Prevention of Infant Mortality. Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysis. Lancet. 2000;355:451–455. - PubMed
-
- Geneva: World Health Organization; 2010. HIV and infant feeding: principles and recommendations for infant feeding in the context of HIV and a summary of the evidence. - PubMed
